$BCDA News Article - BioCardia Reports Published Study Showing Helix Biotherapeutic Delivery System Used in CardiAMP Phase III Heart Failure Trial Has Fewest Adverse Events Among Competitive Delivery Systems
https://marketwirenews.com/news-releases/bioc...49636.html